InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (8 ops.)
Insider track record
ExecutiveDisclosed buys
4
Disclosed sells
8
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by TRABER PETER G, Directeur Médical. Director active across 2 companies, notably Selecta Biosciences INC. In total, 24 reports have been logged. Breakdown: 4 buys · 8 sells. Total volume traded: €275k. History available since 24 May 2021. The latest transaction was disclosed on 25 September 2023 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations24 total
705 shares@ US$1.060.3% of flowCommon StockSEC:0001453687-23-000067:0
8,164 shares@ US$1.13373.2% of flowCommon StockSEC:0001453687-23-000032:0
200,000 shares0Common StockSEC:0001453687-23-000015:0
65,430 shares0Common StockSEC:0001284500-22-000003
65,430 shares0Common StockSEC:0001284500-22-000003:0
3,226 shares@ US$3.08596.6% of flowCommon StockSEC:0001453687-22-000034
3,226 shares@ US$3.08593.3% of flowCommon StockSEC:0001453687-22-000034:0
90,200 shares0Common StockSEC:0001453687-22-000025
90,200 shares0Common StockSEC:0001453687-22-000025:0
4,083 shares@ US$2.98694.1% of flowCommon StockSEC:0001453687-21-000186:0
4,083 shares@ US$2.98693.9% of flowCommon StockSEC:0001453687-21-000186
13,750 shares0Common StockSEC:0001453687-21-000176
13,750 shares0Common StockSEC:0001453687-21-000176:0
3,636 shares@ US$4.395.0% of flowCommon StockSEC:0001453687-21-000144
3,636 shares@ US$4.395.2% of flowCommon StockSEC:0001453687-21-000144:0
13,750 shares0Common StockSEC:0001453687-21-000135:0
13,750 shares0Common StockSEC:0001453687-21-000135
9,100 shares0Common StockSEC:0001453687-21-000121:0
9,100 shares0Common StockSEC:0001453687-21-000121
20,000 shares@ US$3.992524.6% of flowCommon StockSEC:0001453687-21-000078:0
Ideal exit: 20 Feb 2022 (T+270)
20,000 shares@ US$3.992524.6% of flowCommon StockSEC:0001453687-21-000078
Ideal exit: 20 Feb 2022 (T+270)
12,500 shares@ US$3.319812.8% of flowCommon StockSEC:0001453687-21-000074:0
Ideal exit: 18 Feb 2022 (T+270)
12,500 shares@ US$3.319812.8% of flowCommon StockSEC:0001453687-21-000074
Ideal exit: 18 Feb 2022 (T+270)
9,000 sharesCommon StockSEC:0001144204-16-077392:0
24 of 24 declarations
About TRABER PETER G
Peter G Traber is an executive at Selecta Biosciences Inc.
